INnovative Steroid Treatment to reduce Asthma development in children after first-time Rhinovirus-induced wheezing (INSTAR): protocol for a randomised placebo-controlled trial

Trude Elvebakk, Henrik Døllner, Anna Partty, Heidi Jartti, Tytti Vuorinen, Knut Øymar, Silje Nerheim, Nina Moe, Svein Arne Nordbø, Turid Follestad, Johanna Koski, Maria Vollsæter, Anita Hofstad, Claus Klingenberg, Carina Bjørkvoll Leknessund, Håvard Ove Skjerven, Kari Risnes, Cilla Söderhäll, Erle Sissener, Christopher Stephen Inchley, Jon R Konradsen, Tuomas Jartti

Open source

DOI: 10.1136/bmjopen-2025-103530
Published: 2025-07
Container: BMJ Open
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2025-103530,
  title = {INnovative Steroid Treatment to reduce Asthma development in children after first-time Rhinovirus-induced wheezing (INSTAR): protocol for a randomised placebo-controlled trial},
  author = {Trude Elvebakk and Henrik Døllner and Anna Partty and Heidi Jartti and Tytti Vuorinen and Knut Øymar and Silje Nerheim and Nina Moe and Svein Arne Nordbø and Turid Follestad and Johanna Koski and Maria Vollsæter and Anita Hofstad and Claus Klingenberg and Carina Bjørkvoll Leknessund and Håvard Ove Skjerven and Kari Risnes and Cilla Söderhäll and Erle Sissener and Christopher Stephen Inchley and Jon R Konradsen and Tuomas Jartti},
  year = {2025},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2025-103530},
  url = {https://doi.org/10.1136/bmjopen-2025-103530}
}

RIS

TY  - JOUR
TI  - INnovative Steroid Treatment to reduce Asthma development in children after first-time Rhinovirus-induced wheezing (INSTAR): protocol for a randomised placebo-controlled trial
AU  - Trude Elvebakk
AU  - Henrik Døllner
AU  - Anna Partty
AU  - Heidi Jartti
AU  - Tytti Vuorinen
AU  - Knut Øymar
AU  - Silje Nerheim
AU  - Nina Moe
AU  - Svein Arne Nordbø
AU  - Turid Follestad
AU  - Johanna Koski
AU  - Maria Vollsæter
AU  - Anita Hofstad
AU  - Claus Klingenberg
AU  - Carina Bjørkvoll Leknessund
AU  - Håvard Ove Skjerven
AU  - Kari Risnes
AU  - Cilla Söderhäll
AU  - Erle Sissener
AU  - Christopher Stephen Inchley
AU  - Jon R Konradsen
AU  - Tuomas Jartti
PY  - 2025
JO  - BMJ Open
DO  - 10.1136/bmjopen-2025-103530
UR  - https://doi.org/10.1136/bmjopen-2025-103530
ER  -

APA

Elvebakk, T., Døllner, H., Partty, A., Jartti, H., Vuorinen, T., Øymar, K., Nerheim, S., Moe, N., Nordbø, S. A., Follestad, T., Koski, J., Vollsæter, M., Hofstad, A., Klingenberg, C., Leknessund, C. B., Skjerven, H. O., Risnes, K., Söderhäll, C., Sissener, E., Inchley, C. S., Konradsen, J. R., & Jartti, T. (2025). INnovative Steroid Treatment to reduce Asthma development in children after first-time Rhinovirus-induced wheezing (INSTAR): protocol for a randomised placebo-controlled trial. BMJ Open. https://doi.org/10.1136/bmjopen-2025-103530

Source records

crossref · retrieved 2026-09-27T03:10:12.127Z